Communications Biology (May 2022)

IL-25 blockade augments antiviral immunity during respiratory virus infection

  • Teresa C. Williams,
  • Su-Ling Loo,
  • Kristy S. Nichol,
  • Andrew T. Reid,
  • Punnam C. Veerati,
  • Camille Esneau,
  • Peter A. B. Wark,
  • Christopher L. Grainge,
  • Darryl A. Knight,
  • Thomas Vincent,
  • Crystal L. Jackson,
  • Kirby Alton,
  • Richard A. Shimkets,
  • Jason L. Girkin,
  • Nathan W. Bartlett

DOI
https://doi.org/10.1038/s42003-022-03367-z
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 13

Abstract

Read online

IL-25 and its receptor are expressed in airway epithelial cells of healthy individuals and patients with asthma and antibody-mediated blockade of IL-25 enhances antiviral immunity and blocks virus-exacerbated asthma responses.